跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16 条关于
“Niyad”
全部
16
临床试验
6
药物
4
机构
0
资讯
6
去年
Talphera's Niyad Receives FDA Agreement for Enrollment Acceleration in NEPHRO CRRT Trial
去年
CorMedix Makes $5 Million Strategic Investment in Talphera's Phase 3 Anticoagulant Program
上个月
Talphera's nafamostat gains KDIGO endorsement as NEPHRO CRRT trial nears completion
去年
Talphera Shares Surge 20% on NEPHRO CRRT Trial Enrollment Milestone
去年
Talphera Accelerates Nafamostat Trial Enrollment with Strategic Site Optimization
6个月前
Talphera Reaches 50% Enrollment in Nafamostat CRRT Trial, Targets 2026 FDA Filing